LORELCO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lorelco, and when can generic versions of Lorelco launch?
Lorelco is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in LORELCO is probucol. There are six drug master file entries for this compound. Additional details are available on the probucol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LORELCO?
- What are the global sales for LORELCO?
- What is Average Wholesale Price for LORELCO?
Summary for LORELCO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 108 |
Clinical Trials: | 4 |
Patent Applications: | 4,267 |
DailyMed Link: | LORELCO at DailyMed |
Recent Clinical Trials for LORELCO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Otsuka Beijing Research Institute | Phase 1 |
Otsuka Beijing Research Institute | Phase 3 |
Otsuka Beijing Research Institute | N/A |
US Patents and Regulatory Information for LORELCO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-002 | Jul 6, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LORELCO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-002 | Jul 6, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | LORELCO | probucol | TABLET;ORAL | 017535-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LORELCO
See the table below for patents covering LORELCO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 8064 | ⤷ Sign Up | |
Netherlands | 154666 | ⤷ Sign Up | |
Germany | 1767443 | ⤷ Sign Up | |
Netherlands | 6806010 | ⤷ Sign Up | |
United Kingdom | 1168193 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |